Jean Paul Collet, MD, PhD
Jean Paul Collet, MD, PhD

Jean Paul Collet, MD, PhD

Chief Scientific Officer

Dr. Jean-Paul Collet stands as a distinguished senior scientist boasting an impressive portfolio of over 200 peer-reviewed publications, showcasing a pronounced expertise in drug evaluation methodology, economic impact, and outcomes research. Since 2006, he has held the dual roles of Professor and Associate Head of Research within UBC’s Department of Pediatrics. His proactive pursuit of research funding has culminated in the successful acquisition of competitive grants, amassing a total value exceeding $30 million.

Beyond his accolades, Jean-Paul’s influence extends to mentorship, having adeptly guided more than 50 students through the culmination of their Master of Science (MSc), PhD, and postdoctoral endeavors. Evidinno benefits from his wealth of knowledge in real-world evidence and patient-centered research, as he enriches the organization’s research and consulting endeavors.

Jean-Paul’s educational journey is equally remarkable, comprising an MSc in Health Economics from the esteemed Lyon Faculty of Medicine in France and a PhD in Epidemiology from the distinguished McGill University. His comprehensive contributions underscore his commitment to advancing research and shaping the future of the field.

Interests/hobbies: Practicing Tai Chi, hiking, holistic approaches for self-development, and philosophy

Antonia Andonova, PhDMichael del Aguila, PhD

Michael del Aguila

Michael del Aguila comes to Evidinno with 25 years experience in consulting and work inside Life Sciences companies in support of market access and real world evidence generation.  This includes executive positions at Roche, Genentech, Bristol-Myers Squibb and Gilead. 

In BioPharma Michael led teams responsible for sponsored real world evidence and HEOR clinical and observational studies, as well as market access and pricing. His executive leadership in consulting services has included those same domains.

He is pleased to have the opportunity to lead Evidinno’s expansion in product offerings and customer base as we continue our growth trajectory. 

Interests/hobbies: Theater, live music, hiking and running

Jean Paul Collet

Jean-Paul is the Chief Scientific Officer at Evidinno. JP is a trained pediatrician with MSc in Health Economics and PhD in Epidemiology from McGill University. He’s been a Professor and Associate Head Research in the Department of Pediatrics at UBC since 2006. JP’s career in clinical research has been associated with receiving many competing grants (over $30 million), the supervision of over 50 students completing MSc, PhD or Postdoc, and numerous publications (200+) with many of them related to drug evaluation methodology, economic impact and outcomes research.

Interests/hobbies: Practicing Tai Chi and Hiking; Holistic approach for self-development; Philosophy

Masoud Pourrahmat

Masoud Pourrahmat acts as the Head of Operations at Evidinno. With a career spanning over a decade, he possesses extensive expertise in the field of HEOR. Masoud has demonstrated exceptional competence in overseeing and executing targeted or systematic literature reviews, meta-analyses, network meta-analyses, and surrogacy analyses of clinical outcomes. His contributions have encompassed diverse areas such as oncology, neurology, cardiology, endocrinology, immunology, and digital health, among others.

Interests/hobbies: Reading, history, cooking.

Mir Sohail Fazeli

Dr. Mir Sohail Fazeli is the President and Managing Director at Evidinno Outcomes Research Inc. He has over two decades of experience working within academia and industry acting as the principal investigator, project lead, and medical research consultant. His work in evidence synthesis covers a diverse range of methodologies, including systematic and targeted literature reviews of clinical trials and observational studies, meta-analyses, network meta-analyses, and complex statistical modelling studies.